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Detection of microbial constituents by membrane
associated and cytoplasmic pattern recognition
receptors is the essence of innate immunity, leading
to activation of protective host responses. However,
it is still unclear how immune cells specifically
respond to pathogenic bacteria. Using virulent and
nonvirulent strains of Bacillus anthracis, we have
shown that secretion of ATP by infected macro-
phages and the sequential activation of the P2X7
purinergic receptor and nucleotide binding oligomer-
ization domain (NOD)-like receptors are critical for
IL-1-dependent host protection from virulent
B. anthracis. Importantly, lethal toxin produced by
virulent B. anthracis blocked activation of protein
kinases, p38 MAPK and AKT, resulting in opening
of a connexin ATP release channel and induction of
macrophage death. Prevention of cell death or ATP
release through constitutive p38 or AKT activation
interfered with inflammasome activation and IL-1b
production, thereby compromising antimicrobial
immunity.
INTRODUCTION
Two major types of pattern recognition receptors (PRRs)—Toll-
like receptors (TLRs) and NOD-like receptors (NLRs)—recognize
microbial components and activate mammalian innate immunity
(Meylan et al., 2006). TLRs are directly activated by microbial
components collectively known as pathogen-associated molec-
ular patterns (PAMPs), but the mechanism of NLR activation is
more obscure and complex (Martinon et al., 2009). Despite their
name, most PAMPs, including lipopolysaccharides, peptidogly-
cans, lipopeptides, and flagellin, are expressed by virulent and
nonvirulent bacteria alike. Thus, it is not entirely clear how
immune cells discriminate between nonvirulent commensals34 Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc.and virulent pathogens or nonvirulent and virulent variants of
the same bacterial species. One signaling system that seems
capable of such discrimination is the NLR-activated inflamma-
some system (Martinon et al., 2009). Inflammasomes are
NLR-containing multiprotein complexes that control activation
of caspase-1 and the processing and secretion of proinflamma-
tory cytokines interleukin (IL)-1b and IL-18 (Martinon et al., 2009).
Inflammasome activators include certain PAMPs and danger-
associated molecular patterns (DAMPs), such as proteins
released by dying cells, extracellular ATP, reactive oxygen
species (ROS), urea crystals, and bacterial poreforming toxins
such as listeriolysin O of Listeria monocytogenes and alpha-
hemolysin of Staphylococcus aureus (Franchi et al., 2009; Hruz
et al., 2009; Mariathasan et al., 2004). The pathways connecting
these elicitors of inflammasome activation remain largely
unknown.
We have investigated the mechanisms that allow a toxin-
producing strain of the Gram-positive bacterial pathogen
Bacillus anthracis, the causative agent of anthrax (Tournier
et al., 2009), to activate the inflammasome, whereas non-toxin-
producing derivatives of the same strain do not. Anthrax patho-
genesis depends on production of lethal toxin (LT) and edema
toxin (ET) (Moayeri and Leppla, 2009). LT is composed of two
subunits, protective antigen (PA), which also serves as a subunit
of ET, and lethal factor (LF), a zinc metalloprotease that specifi-
cally cleaves the N termini of mitogen-activated protein kinase
(MAPK)-kinases (MEK or MKK) within the host cell (Moayeri
and Leppla, 2009). Importantly, LF-dependent inhibition of p38
MAPK results in macrophage apoptosis (Park et al., 2002). LT
can also induce assembly of the NALP1 inflammasome (Boyden
and Dietrich, 2006; Bruey et al., 2007; Faustin et al., 2007; Hsu
et al., 2008). However, it is not clear whether LT is directly recog-
nized as a PAMP by NALP1 or whether its catalytic activity
promotes inflammasome activation indirectly. Another enigma
is the host-based variation in NALP1 inflammasome activation
by LT, caused by genetic polymorphisms in the Nalp1b locus
(Boyden and Dietrich, 2006). Notably, live B. anthracis can
induce IL-1b production also in mouse strains, such as
C57BL/6 (Hsu et al., 2008), whose macrophages are refractory
to LT-induced NALP1 activation (Boyden and Dietrich, 2006).
Figure 1. Molecular Constituents of B. anthracis-Activated Inflammasomes
(A) Peritoneal macrophages from C57BL/6mice were infected with B. anthracis at a multiplicity of infection (MOI) = 2. When indicated, macrophage lysates were
prepared and immunoprecipitated (IP) with a caspase-1 antibody. Composition of the immunoprecipitates was examined by immunoblotting of three different
blots of the same experiment, which was repeated twice with similar results.
(B) Macrophages from the indicated mouse strains were infected with B. anthracis as above. After 8 hr, IL-1b in the culture medium wasmeasured by ELISA. This
and all similar experiments were repeated at least 3 times and the results of one representative experiment done in triplicates are shown. Values represent
means ± SD. **p < 0.01 denote significant differences between the groups.
(C) Macrophages were infected as above and 3 hr later amounts of pro-IL-1b mRNA were measured by quantitative reverse transcriptase polymerase chain
reaction (Q-RT-PCR). Results were normalized to the amount of GAPDHmRNA. Values represent means ± SD. *p < 0.05 denotes significant differences between
the groups. This experiment was repeated three times and the results of one representative experiment done in triplicates are shown.
(D) WT and Ripk2/ macrophages were infected with B. anthracis as above and release of active caspase-1 (p10) and IL-1b (p17) to the culture medium was
examined after 12 hr by immunoblotting. This experiment was repeated twice with similar results.
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p38 Inhibition Promotes Inflammasome ActivationGiven these differences and complications, we pursued studies
with isogenic live bacterial strains that differ in LT production
rather than use purified LT in the absence of other bacterial
components.
Using isogenicB. anthracis strains that differ only in LF expres-
sion, we found that LT affects the host response in a manner
dependent on activation of NALP1 and caspase-1 and that
a LF-deficient strain cannot induce inflammasome activation.
Specifically, LT-dependent inhibition of p38 and AKT signaling
resulted in release of ATP from infected macrophages through
connexin channels leading to subsequent inflammasome activa-
tion mediated by the ATP-responsive P2X7 purinergic receptor.
This pathway plays a critical role in protecting the host from
LT-producing B. anthracis.
RESULTS
RIP2 and IPAF Are Required for B. anthracis-Mediated
Inflammasome Activation
B. anthracis infection activates a NALP1 inflammasome complex
leading to IL-1b processing and secretion (Hsu et al., 2008). To
elucidate the composition of the B. anthracis-activated NALP1inflammasome complex, we infected murine peritoneal macro-
phages with B. anthracis (Sterne strain), at a multiplicity of
infection (MOI) of 2 bacteria/cell. Cell lysates were immunopre-
cipitated with a caspase-1 antibody and then immunoblotted
for candidate NLRs and adaptor proteins. B. anthracis infection
induced association of NALP1, NOD2, RIP2, and IPAF (NLRC4)
with caspase-1 (Figure 1A). By contrast, NALP3 and ASC were
not present in caspase-1 immunoprecipitates after B. anthracis
infection.
To determine whether IPAF and RIP2 are required for
B. anthracis-induced IL-1b secretion, we infected wild-type
(WT), Nlrc4/ or Ripk2/macrophages as above and analyzed
IL-1b secretion by ELISA. Ripk2/ and Nlrc4/ macrophages
released significantly less IL-1b upon B. anthracis infection
than WT macrophages (Figure 1B). By contrast, RIP2 or IPAF
made little contribution to induction of pro-IL-1b mRNA in
B. anthracis-infected macrophages (Figure 1C). Ripk2 ablation
also did not decrease the expression of caspase-1, Nod2,
Nalp1 and Nalp3 mRNAs (Figure S1 available online). Notably,
RIP2 was important for B. anthracis-induced caspase-1 activa-
tion and processing as detected by the release of the caspase-1
p10 fragment along with mature (p17) IL-1b (Figure 1D).Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc. 35
Figure 2. B. anthracis-Induced Inflammasome Activation Depends on LF and Inhibition of p38
(A and B) C57BL/6 macrophages were infected with WT (BA) or DLF B. anthracis. At the indicated times, cell lysates were analyzed by immunoblotting of two
separate gels of the same experiment for MEK proteolysis (A) and MAPK phosphorylation (B).
(C and D) RAW264.7 macrophages were transfected with MEK6DCR or an empty vector. Transfected cells were left uninfected or infected with B. anthracis
and 1 hr later cell lysates were prepared and analyzed for p38 phosphorylation by immunoblotting (C). Lactate dehydrogenase (LDH) release to the culture
supernatant was measured after 4 hr of infection (D). Results are means ± SD; **p < 0.01 denote significant differences between the groups.
(E and F) RAW264.7 cells were transfected and infected as above. After 8 hr, IL-1b (E) and IL-6 (F) in culture supernatants were measured by ELISA. Results are
means ± SD; **p < 0.01 denote significant differences between the groups.
All experiments were repeated at least three times and the results of one representative experiment are shown.
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p38 Inhibition Promotes Inflammasome ActivationB. anthracis Activates the NALP1 Inflammasome
in a p38-Dependent Manner
LF, the active component of LT, is a protease that cleaves the
N termini of allMEKs (orMKKs)with the exception ofMEK5 (Vitale
et al., 2000). As expected, infection of macrophages with WT
B. anthracis Sterne strain led to disappearance of full-length
MEK1, MEK4, and MEK6 (Figure 2A and Figure S2A). All three
proteins remained intact in macrophages infected with an
isogenic LF-deficient mutant of the B. anthracis Sterne strain
(DLF). Correspondingly, infection of macrophages with the DLF
mutant triggered much stronger activation of ERK, JNK, and
p38MAPKs thandid infectionwith the parentalB. anthracis strain
(WT; Figure 2B). WhereasWTB. anthracis induced IL-1b release,
infectionwith theDLFstraindid not (FigureS2B). Accordingly,WT
but not DLF B. anthracis induced association of caspase-1 with
NOD2 (Figure S2C). To determine whether LF-mediated inhibi-
tion of MAPK activation contributes to inflammasome activation
and IL-1b secretion, we treated DLF-infected macrophages
with different MAPK and MEK inhibitors (PD98059, an inhibitor
of MEK1 and MEK2 which activate ERK, SP600125 to inhibit
JNK, andSB202190 forp38aandb isoforms).However, inhibition36 Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc.of p38, JNK, or ERK signaling in DLF-infected macrophages
failed to restore IL-1b secretion (Figure S2B). However, as previ-
ously reported (Park et al., 2002), the p38 inhibitor reduced IL-1b
mRNA inDLF-infected macrophages to amounts similar to those
found in WT B. anthracis-infected cells (Figure S2B). Activation
of p38 regulates CREB (c-AMP response element binding
transcription factor) activity that is required for transcriptional
regulation of several molecules including plasminogen activator
inhibitor-2 (PAI-2), cyclooxygenase-2 (COX-2), and IL-1b (Park
et al., 2005). Notably, the amounts of IL-1b mRNA induced by
the DLF mutant were considerably higher than the amounts of
IL-1bmRNA induced by WT B. anthracis.
Because of the interference of p38 inhibition with optimal IL-1b
mRNA induction, we undertook a different approach to examine
whether MEK6 cleavage and inhibition of p38 activation
contribute to inflammasome activation. We thus transfected
RAW264.7 macrophages with a construct encoding MEK6DCR,
a variant form of MEK6 that is resistant to the inhibitory effect of
LF (Park et al., 2002). RT-PCRwith mutant gene-specific primers
confirmed MEK6DCR mRNA expression in transfected RAW
264.7 macrophages (Figure S2D); amounts were comparable
Figure 3. B. anthracis-Induced Cell Death and Inflammasome Activation Depend on AKT Inhibition
(A) RAW264.7 cells were infected with WT (BA) or DLF B. anthracis and 2 hr later, cell lysates were prepared and analyzed by immunoblotting for AKT Ser473
phosphorylation.
(B) RAW264.7 cells were retrovirally transduced with myr-AKT or an empty vector. Transduced cells were left uninfected or infected with B. anthracis. LDH in
culture supernatants was measured 4 hr later. Results are means ± SD; **p < 0.01 denote significant differences between the groups.
(C) RAW264.7 cells were transfected with MEKD6CR or an empty vector. Transfected cells were left uninfected or infected with B. anthracis and 2 hr later, cell
lysates were prepared and analyzed by immunoblotting for AKT phosphorylation.
(D) Myr-AKT-transduced or control RAW264.7 cells were infected with B. anthracis as above. After 1 hr, cell lysates were prepared and analyzed by immuno-
blotting of two separate gels for AKT and p38 phosphorylation.
(E and F) RAW264.7 cells transfected with myr-AKT or an empty vector were infected as above. IL-1b (E) and IL-6 (F) in culture supernatants were measured 8 hr
after infection by ELISA. Results are means ± SD; **p < 0.01.
All experiments were repeated at least three times and the results of one representative experiment are shown.
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p38 Inhibition Promotes Inflammasome Activationto those of WT MEK6 mRNA in these cells (data not shown).
Overexpression of MEK6DCR in B.anthracis-infected macro-
phages restored p38 MAPK activation (Figure 2C). As found
previously using purified LT (Park et al., 2002), overexpression
of MEK6DCR prevented B.anthracis-induced cell death (Fig-
ure 2D). MEK6DCR expression also completely blocked IL-1b
release in response to WT B. anthracis infection (Figure 2E). In
contrast, IL-6 release was increased by MEK6DCR expression
(Figure 2F) and induction of IL-1b mRNA was also slightly
enhanced (Figure S2E). In conclusion, MEK6 cleavage by LF is
required for IL-1b release byB. anthracis-infectedmacrophages.
LF-Mediated Inhibition of AKT Contributes
to IL-1b Release
AKT is a serine-threonine protein kinase with important roles in
multiple cellular processes. LF inhibits T cell receptor-induced
AKT activation (Comer et al., 2005). We observed LF-dependent
inhibition of AKT activation in macrophages, as evidenced byelevated AKTS473 phosphorylation inDLF-infected cells relative
to cells infected with WT B. anthracis (Figure 3A). We postulated
that reduced AKT activity could also contribute to B. anthracis-
induced cell death and IL-1b release along with inhibition of
p38 activation. To test this hypothesis, we transduced macro-
phages with retroviral vectors containing a constitutively active
variant of AKT (myristoylated-AKT or myr-AKT) or no insert
and were then infected them with B. anthracis. Myr-AKT ex-
pressing macrophages were significantly protected from
B. anthracis-induced cell death (Figure 3B), suggesting an
important contribution of AKT to host cell survival during infec-
tion. Given the protective functions of both p38 and AKT, we
explored the possibility of crosstalk between the two kinases.
Using MEK6DCR-expressing RAW264.7 cells, we found that
expression of cleavage-resistant MEK6DCR enhanced AKT acti-
vation in B. anthracis-infected cells (Figure 3C). However,
expression of myr-AKT did not prevent inhibition of p38 activa-
tion in B. anthracis-infected macrophages (Figure 3D). Thus,Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc. 37
Figure 4. B. anthracis Induces ATP Release from Infected Macrophages in LF-, p38- and AKT-Dependent Manner
(A) C57BL/6 macrophages were infected with WT (BA) or DLF B. anthracis. At the indicated times points, ATP in the culture supernatants was measured. This
experiment was repeated at least four times and the results of one representative experiment done in triplicates are shown. Results are means ± SD; *p < 0.05,
**p < 0.01 denote significant differences between the groups.
(B and C) Mouse macrophages were infected with WT (BA) or DLF B. anthracis in the absence or presence of KN-62 (10 mM). After 8 hr, IL-1b (B) and IL-6 (C) in
culture supernatants were measured by ELISA. This experiment was repeated three times and the results of one representative experiment done in triplicates are
shown. Results are means ± SD; **p < 0.01 denote significant differences between the groups.
(D) RAW264.7 cells transfected with MEK6DCR, myr-AKT, or empty vector were left uninfected or infected with B. anthracis and 2 hr later ATP release to culture
supernatants was measured. This experiment was repeated three times and the results of one representative experiment done in triplicates are shown.
(E) C57BL/6 macrophages were infected with WT B. anthracis in the absence or presence of 130 mM KCl, and 8 hr later the amount of IL-1b in culture super-
natants was determined by ELISA. This experiment was repeated three times and the results of one representative experiment done in duplicates are shown.
Results are means ± SD; **p < 0.01 denote significant differences between the groups.
(F) Mouse macrophages were infected with WT B. anthracis in the absence or presence of KN-62 (10 mM) or KCl (130 mM), and at the indicated times cell lysates
were prepared and analyzed by immunoblotting of two separate gels from the same experiment for MEK proteolysis. This experiment was repeated three times
and the results of one representative experiment are shown.
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p38 Inhibition Promotes Inflammasome ActivationB. anthracis-mediated inhibition of p38 activation prevents AKT
phosphorylation in infected macrophages, but AKT activation
does not affect p38 activity. Nonetheless, expression of
myr-AKT blocked IL-1b release without affecting IL-6 release
by infected macrophages (Figures 3E and 3F). Thus, inhibition
of both p38 and AKT is required for inflammasome activation
and IL-1b release in B. anthracis infected macrophages.
ATP Secretion Is Required for Inflammasome Activation
upon B. anthracis Infection
ATP is released from mononuclear phagocytes stimulated with
various PAMPs (Piccini et al., 2008) and extracellular ATP is one38 Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc.of the most pleiotropic inflammasome activators (Ogura et al.,
2006). To examine a potential role for ATP inB. anthracis-induced
inflammasome activation, we measured extracellular ATP
released from macrophages infected with either WT or the DLF
mutant B. anthracis. Infection with WT B. anthracis resulted in
time-dependent ATP release, but this was not seen in macro-
phages infected with the DLF mutant (Figure 4A). Cell death
was minimal (3%–5%) at 3 hr postinfection, suggesting that
macrophage death may not be the direct cause of early ATP
release. To determine whether the secreted ATP contributed to
inflammasome activation, we blocked ATP signaling via the
P2X7 purinergic receptor with the antagonist KN-62 (Di Virgilio,
Immunity
p38 Inhibition Promotes Inflammasome Activation2007b; Piccini et al., 2008). P2X7 blockade abolished
B. anthracis-induced IL-1b secretion (Figure 4B), without
affecting pro-IL-1bmRNA synthesis (data not shown). Secretion
of IL-6 by B. anthracis-infected macrophages was unaffected by
P2X7 blockade (Figure 4C), suggesting an inflammasome-
specific phenomenon rather than a general requirement for
P2X7 in cell activation or cytokine secretion. If lack of ATP
accounts for inability of DLF mutant-infected macrophages to
activate caspase-1, we hypothesized that cotreatment with
exogenous ATP should compensate for this difference. Indeed,
IL-1b release was detected in the culture medium of DLF
mutant-infectedmacrophages upon concomitant ATP treatment
(Figure S3A). In fact, in the presence of exogenous ATP, the DLF
mutant induced more IL-1b secretion than WT B. anthracis.
Furthermore, release of ATP from B. anthracis-infected
macrophages was blocked by expression of constitutively active
myr-AKT or MEK6DCR (Figure 4D), suggesting a role for LF-
mediated inhibition of p38 and AKT signaling in triggering ATP
release. Overexpression of either p38 or AKT by itself had no
inhibitory effect on inflammaosme activation, given that induc-
tion of IL-1b release by cotreatment of DLF + ATP was unaf-
fected by MEK6DCR or myr-AKT expression in RAW264.7 cells
(Figure S3B and data not shown). In contrast to p38 and AKT
signaling, caspase-1 was dispensable for ATP secretion as
similar amounts of ATP were released from B. anthracis-infected
WT and Casp1/ macrophages (Figure S3C).
Activation of P2X7 by ATP causes rapid K+ efflux from the
cytosol and release of intracellular Ca2+ (Di Virgilio, 2007b). To
study the role of these events in B. anthracis- induced IL-1b
release, we blocked K+ efflux by increasing extracellular KCl to
130 mM. Blockade of K+ efflux inhibited B. anthracis-induced
IL-1b secretion without affecting pro-IL-1b mRNA expression
(Figure 4E and data not shown). Neither extracellular KCl- nor
KN-62-mediated blockade of P2X7 affected MEK proteolysis in
B. anthracis-infected macrophages (Figure 4F and Figure S3D),
indicating that the observed inhibition of IL-1b release is not
due to alterations in the infection process or LF catalytic activity.
AKTPrevents ATPRelease byControlling aConnexin-43
Channel
The above experiments suggested that ATP released by
B. anthracis-infected macrophages is a key signal for acti-
vation of inflammasome-dependent host immunity. Live cells
release ATP through a number of channels, including volume-
sensitive channels, pannexin channels, and connexin channels
(Chekeni et al., 2010; Faigle et al., 2008; Pangrsic et al., 2007;
Sabirov et al., 2001), as well as through vesicular exocytosis
(Pangrsic et al., 2007). To examine the potential involvement of
the connexin-43 channel (Eltzschig et al., 2006; Faigle et al.,
2008) in B. anthracis induced ATP release, we infected mouse
macrophages with B. anthracis in the presence or absence of
the connexin-43 inhibitor, carbenoxolone (CBX) (Kang et al.,
2008). Notably, release of ATP by B. anthracis-infected macro-
phages was attenuated after CBX exposure (Figure 5A). In
contrast, CBX treatment did not inhibit lactate dehydrogenase
(LDH) release; on the contrary, CBX-treated macrophages ex-
hibited enhanced LDH release (Figure 5B). To analyze the role
of connexin-43 in inflammasome activation, we infected mouse
macrophages with B. anthracis in the presence or absence ofCBX, and IL-1b and caspase-1 secretion were examined. Incu-
bation with CBX inhibited secretion of activated caspase-1 and
IL-1b by B. anthracis-infected macrophages (Figure 5C and Fig-
ure S4A). Because CBX may affect other pathways (Chekeni
et al., 2010; Faigle et al., 2008; Pangrsic et al., 2007; Sabirov
et al., 2001), we validated our results by using shRNA-mediated
silencing of connexin-43. shRNA-mediated silencing of con-
nexin-43 (Figure 5D) reduced B. anthracis-induced ATP (Fig-
ure 5E), caspase-1, and IL-1b release (Figure 5F) compared to
control-treated cells. Neither B. anthracis-induced IL-1b mRNA
expression nor cell deathwere affected by connexin-43 silencing
(data not shown). Collectively, the connexin-43 silencing studies
and pharmacological inhibition by CBX support a role for con-
nexin-43 in ATP release and inflammasome activation during
B. anthracis infection.
Connexin-43 has multiple serine residues that can be phos-
phorylated by PKC, MAPK, or AKT (Kang et al., 2008) and the
phosphorylation of connexins negatively regulates their opening
(Faigle et al., 2008). Because B. anthracis inhibits activation of
MAPKs and AKT, we investigated whether inhibition of these
protein kinases impacts the phosphorylation of connexin-43. In
noninfected macrophages, connexin-43 was phosphorylated
at Ser279 and Ser282 on the basis of reactivity with a phos-
pho-specific connexin-43 antibody (Leykauf et al., 2003).
Initially, B. anthracis infection enhanced connexin-43 phosphor-
ylation, but after 2 hr connexin-43 phosphorylation was almost
completely abolished (Figure 5G). In contrast, infection of
macrophages with DLF B. anthracis had no inhibitory effect on
connexin-43 phosphorylation (Figure 5H). The kinetics of con-
nexin-43 dephosphorylation correlated with the kinetics of ATP
release (Figure S4B). To gain further insight into the regulation
of connexin-43 phosphorylation, we examined it in RAW264.7
cells expressing myr-AKT. Notably, expression of constitutively
active myr-AKT, which inhibits ATP release and inflammasome
activation in infected macrophages (Figures 4D and 3E), pre-
vented the B. anthracis-induced decrease in connexin-43
phosphorylation (Figure 5H). Together, our results suggest that
LT-dependent inhibition of p38 and AKT signaling results in
opening of connexin-43 channel and ATP release for inflamma-
some activation (Table S1).
IL-1b Production Protects Mice from B. anthracis
IL-1b signaling plays a prominent role in immune and inflamma-
tory responses (Meylan et al., 2006; Miller et al., 2006). To
determine the immunological role ofB. anthracis-induced inflam-
masome activation and IL-1b production, we infected WT
C57BL/6 mice and different mutants in the same genetic back-
ground with WT or DLF B. anthracis. Although C57BL/6 mice
are resistant to pharmacological challenge with purified LF
(Boyden and Dietrich, 2006), they died when infected with WT
B. anthracis but not upon infection with the DLF mutant (Fig-
ure S5A). Interestingly, the C57BL/6 strain exhibited enhanced
B. anthracis-induced mortality relative to the Balb/c strain (Fig-
ure S5B), in contrast to the response elicited by purified LT in
the two strains (Moayeri et al., 2003). Although purified edema
toxin causes lethality of Balb/c mice (Moayeri and Leppla,
2009), DLF that expresses intact ET was unable to induce
mortality in C57BL/6 (Figure S5A) as well as in Swiss mice (Pe-
zard et al., 1991). Infected mice cleared DLF mutant bacteriaImmunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc. 39
Figure 5. B. anthracis-Induced ATP Release and Inflammasome Activation Depend on Connexin-43
(A–C) C57BL/6macrophages were infected with B. anthracis as above and 45 min later the connexin-43 inhibitor carbenoxolone (CBX, 2.5 mM) was added to the
culture medium. ATP release was measured 1 hr later (A) and LDH release was measured after 2 hr (B). Secretion of active caspase-1 (p10) and IL-1b (p17) to the
culture medium was examined 12 hr after CBX addition. Cellular actin was used as a control. This experiment was repeated three times and the results of one
representative experiment are shown.
(D) RAW264.7 cells were transduced with lentiviruses expressing connexin-43 shRNA or control shRNA (Ctrl.). Connexin-43 expression in the transduced cells
was analyzed by immunoblotting. This experiment was repeated two times and the results of one representative experiment are shown.
(E and F) RAW264.7 cells were transduced with lentiviruses expressing connexin-43 shRNA or control shRNA. Transduced cells were left uninfected or infected
withB. anthracis. ATP release wasmeasured 2 hr later (E). Caspase-1 (p10) and IL-1b (p17) secretion was examined after 12 hr (F). This experiment was repeated
twice and the results of one representative experiment are shown. Results are means ± SD; **p < 0.01 denote significant differences between the groups.
(G) C57BL/6macrophages were treated as above and at the indicated times cell lysates were prepared and analyzed by immunoblotting for phosphorylation of
connexin-43 at Ser279 and Ser282. This experiment was repeated three times and the results of one representative experiment are shown.
(H) Myr-AKT-expressing or parental RAW264.7 cells were infected as above. After 2 hr, cell lysates were prepared and analyzed by immunoblotting for connexin-
43 phosphorylation and tubulin content. This experiment was repeated three times and the results of one representative experiment are shown.
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p38 Inhibition Promotes Inflammasome Activationfrom their spleen more efficiently than WT B. anthracis (Figures
S5C). Furthermore, WT B. anthracis, but not the DLF mutant,
induced cell death in spleens of infected mice (data not shown).
These results demonstrate that lethal B. anthracis infection of
C57BL/6 mice is indeed LF-dependent.
Both caspase-1 (Casp1/) and IL-1 receptor (Il1r/) deficient
mice exhibited enhanced mortality upon infection with WT
B. anthracis relative to WT mice (Figure 6A). Furthermore,
B. anthracis-infected mice displayed enhanced mortality when
treated with Anakinra (Kineret), an FDA-approved IL-1 receptor
(IL-1R) antagonist (Figure 6A). No mortality of either WT or
Casp1/ mice was seen upon infection with the DLF mutant
(data not shown). Furthermore, infection with a low inoculum
(0.5 3 106 cfu/mouse) that had no effect on survival of WT
mice was sufficient to induce mortality of Casp1/ mice (Fig-
ure S5D). Together, the results suggest that inflammasome40 Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc.activation and IL-1b signaling are critical for innate immunity to
LT-producing B. anthracis. Furthermore, counter to previous
expectations (Boyden and Dietrich, 2006), assembly of inflam-
masome components and caspase-1 activation was not the
cause of B. anthracis-induced mortality. Consistent with these
observations, mice deficient in critical LF-responsive inflamma-
some components, including Nlrc4/, Ripk2/, and Nod2/
mice, also exhibited enhanced mortality upon B. anthracis
infection (Figure 6B).
To determine the effect of reduced inflammasome responses
in Casp1/ mice on host leukocytes, we harvested spleens
from B. anthracis-infected WT and Casp1/ mice 3 days after
infection and evaluated cell death by TUNEL staining. In contrast
to previous reports that LT-induced cell death in vitro is cas-
pase-1 dependent (Boyden and Dietrich, 2006), we observed
a dramatic increase in splenocyte death in Casp1/ mice
Figure 6. Inflammasome Activation Protects Mice from B. anthracis Infection
(A and B) Mice of the indicated genotypes were infected with WT B. anthracis (23 106 cfu/mouse given i.p., n = 5–8 mice per group). Where indicated, Anakinra
(Kineret, IL-1RA, 100 mg/kg) was s.c. injected every 6 hr over a period of 24 hr after infection. Mouse survival was analyzed over the course of 6 days after
infection. This experiment was repeated three times and the results of one representative experiment are shown.
(C) WT and Casp1/mice were infected as above and 48 hr later their spleens were collected and examined for cell death by a TUNEL assay. The experiment
was repeated twice with similar results.
(D) Macrophages from WT and Casp1/mice were infected with WT B. anthracis and at the indicated times, LDH release was measured. This experiment was
repeated three times and the results of one representative experiment done in triplicates are shown. Results are means ± SD; *p < 0.05 denote significant
differences between the groups.
(E) Macrophages fromWT and Casp1/mice were infected with WT B. anthracis and at the indicated times intracellular bacterial counts were determined. This
experiment was repeated three times and the results of one representative experiment done in triplicates are shown. Results are means ± SD; *p < 0.05 denote
significant differences between the groups.
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decreased bacterial clearance from spleens of Casp1/ mice
(data not shown).
Although neutrophils dominate IL-1b-dependent responses to
bacterial challenge (Miller et al., 2007), downstream effects of
IL-1b signaling during bacterial infection have not been well
studied. To determine how inflammasome activation benefits
the infected host, peritoneal macrophages from WT and
Casp1/mice were challenged with B. anthracis and cell death
was assessed by LDH release. As found in vivo, Casp1/
macrophages exhibited enhanced death (Figure 6D) and
impaired bacterial clearance (Figure 6E). Corroborating that
caspase-1 exerts its effect through IL-1b, Anakinra treatment
also increased the extent of macrophage death in response to
infection with WT, but not DLF, B. anthracis (Figure S5E).
Because survival of pathogen-activated macrophages depends
on p38 and NF-kB activation (Park et al., 2002), we examined
whether caspase-1 was required for induction of NF-kB targetgenes inB. anthracis-infectedmacrophages. Indeed, expression
of several known NF-kB target genes in mouse macrophages,
including Ptgs2 and Nos2, was higher in WT macrophages
relative to Casp1/ macrophages 4 hr after infection with WT
B. anthracis (Figure S5F and data not shown). Nonetheless and
despite existence of this amplification loop, at very early stages
of macrophage infection, both WT and DLF B. anthracis led to
similar NF-kB activation responses as indicated by the kinetics
and extend of IkBa degradation (Figure 2B). Collectively, these
findings indicate a critical role of IL-1b in mounting immunity
against virulent B. anthracis.
DISCUSSION
We have used two B. anthracis strains that differ in expression of
LF, an essential component of LT, a critical virulence factor, to
interrogate how the host innate immune system discriminates
between virulent and nonvirulent bacteria. Our results indicateImmunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc. 41
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elicited by the two bacteria lies in their ability to activate the
inflammasome system and induce IL-1b secretion. Yet, both
B. anthracis strains were equally effective in their ability to induce
IkB degradation, a response that is most likely dependent on
TLR activation. In fact, at early time points after infection, the
nonvirulent bacterium led to more effective induction of IL-1b
mRNA and IkBa resynthesis, responses that depend on activa-
tion of both NF-kB andMAPKs (Park et al., 2005). IL-1b secretion
was essential for host protection against WT B. anthracis,
attenuation of macrophage death, and bacterial clearance.
Dissection of themolecular events involved inB. anthracis-medi-
ated inflammasome activation revealed that the key difference
between the two strains lies in their ability to induce ATP release
from infected macrophages. Our results strongly suggest that
the major source of ATP release from B. anthracis-infected
macrophages is the connexin-43 ATP-release channel. Whereas
WT B. anthracis induces dephosphorylation and presumably
opening of connexin-43, the nonvirulent DLF mutant fails to do
so. Most likely, connexin-43 is dephosphorylated in WT
B. anthracis-infected cells as a result of inhibition of AKT, one
of several protein kinases known to keep connexin-43 in a closed
state (Park et al., 2007; Solan and Lampe, 2007; Spinella et al.,
2003; Warn-Cramer et al., 1996). In addition to elucidating the
mechanism of B. anthracis-induced inflammasome activation,
our results demonstrate that inflammasomes, containing
NALP1, NOD2, RIP2, and IPAF, were responsible for discrimina-
tion between virulent and nonvirulent B. anthracis. Interestingly,
however, inflammasomes are not directly responsible for
recognition of LF, the one molecule that differs between the
two bacterial strains used in this study. Rather, the inflamma-
somes that are activated upon B. anthracis infection are respon-
sive to K+ ions, whose efflux is stimulated by the ATP that is
released from infected cells. Thus, it is the inflammasome, and
not the TLR system, that is responsible for recognition of
‘‘danger’’ (Meylan et al., 2006), which in this case is caused by
infection with virulent, LT-producing, B. anthracis. The initial
induction of IL-1b mRNA, which depends on activation of
NF-kB and other transcription factors, is most likely due to
recognition of PAMPs, which are present on both virulent and
nonvirulent bacteria, by different TLRs expressed by the infected
macrophage.
Our results suggest that upon virulent B. anthracis infection,
caspase-1 interacts with NALP1, NOD2, RIP2, and IPAF, but
it is not clear whether all of these molecules form a single
inflammasome complex. In vitro studies using purified LT in the
absence of other B. anthracis components has identified
NALP1 as a key component of the LT-activated inflammasome
(Boyden and Dietrich, 2006). In these studies, however, LT acti-
vated the NALP1 inflammasome only inBalb/cmacrophages but
not C57BL/6 macrophages, and the differential response was
attributed to polymorphisms at the Nalp1 locus (Boyden and
Dietrich, 2006). The molecular mechanism by which these poly-
morphisms affect NALP1 activation was never identified, neither
was it shown that LT or LF is directly recognized by NALP1. Our
results indicate that although less responsive to purified LT,
C57BL/6 macrophages are perfectly capable of responding to
live B. anthracis, which is the only physiologically relevant route
of LT delivery into these cells. Furthermore, C57BL/6 mice42 Immunity 35, 34–44, July 22, 2011 ª2011 Elsevier Inc.succumbed to infection with WT B. anthracis and the mortality
was fully dependent on LT production. Because NALP1 is
unlikely to be directly involved in LT (or LF) recognition, it is
plausible that when encountering recombinant LT, which may
not be as active as the bacterially produced toxin within the
host macrophage, Balb/c macrophages may be more sensitive
to ATP or ATP-induced K+ efflux than C57BL/6 macrophages,
a difference that is due to expression of different NALP1 variants.
It should also be noted that in vitro, macrophage killing by LT is
caspase-1 dependent, whereas in vivo, at least inC57BL/6mice,
caspase-1 activation is important for host protection. Further-
more, the C57BL/6 strain is more susceptible to B. anthracis-
induced mortality than the Balb/c strain, in contrast to the
in vitro response elicited by purified LT in macrophages of the
two strains (Boyden and Dietrich, 2006), but in agreement with
another in vivo infection study using the Sterne strain of
B. anthracis (Welkos et al., 1986). Furthermore, purified LT
induced enhanced mortality in Balb/c mice relative to C57BL/6
mice (Moayeri et al., 2003). Clearly, the response to the intact
bacterium is entirely different from the response to the purified
toxin.
Previously, we found that B. anthracis infection of macro-
phages induces NALP1- and NOD2-dependent caspase-1 acti-
vation and IL-1b release (Hsu et al., 2008). These NLRs could be
involved in sensing of peptidoglycans or other PAMPs produced
by this Gram-positive bacterium (Martinon, 2007; Schroder and
Tschopp, 2010). However, both toxigenic and nontoxigenic
B. anthracis are probably identical in the PAMPs they express
and the key to their differential ability to activate caspase-1 lies
in their differential ability to induce ATP release from infected
macrophages. Addition of exogenous ATP to macrophages in-
fected with the nonvirulent DLF mutant restored inflammasome
activation and IL-1b secretion. Consistent with previous publica-
tions (Di Virgilio, 2007a, b; Piccini et al., 2008), we find that ATP is
likely to cause inflammasome activation through engagement of
the P2X7 purinergic receptor and induction of K+ efflux.
Multiple mechanisms can mediate release of intracellular ATP
in response to mechanical stimulation, stress, osmotic swelling,
or shrinking of cells, physical perturbation, or host-pathogen
interactions (Corriden and Insel, 2010; Piccini et al., 2008).
Various membrane channels can release ATP, including con-
nexin and pannexin hemichannels, maxianion channels, and
volume-regulated anion channels (Corriden and Insel, 2010). In
addition to channel-mediated release, ATP can be released by
exocytotic mechanisms in neurons or by membrane permeabili-
zation in dying cells (Chekeni et al., 2010; Faigle et al., 2008;
Pangrsic et al., 2007; Sabirov et al., 2001). ATP release was
previously shown to be associated with induction of macro-
phage death through a process that has been named pyroptosis
(Iyer et al., 2009), which was implicated in IL-1b release nearly
20 years ago (Hogquist et al., 1991). Indeed, LT by virtue of its
ability to inhibit p38 activation can promote macrophage death
(Park et al., 2002). Activation of p38 is required for synthesis of
several antiapoptotic molecules including Bfl1 and PAI-2 (Park
et al., 2005), and as we show here, it is also needed for mainte-
nance of AKT activity. Furthermore, the release of ATP from
B. anthracis-infected macrophages is strongly inhibited by
activation of either p38 or AKT but is independent of caspase-1
activation. Rather than be a direct and nonspecific consequence
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B. anthracis-infected macrophages depends on the opening of
connexin-43 channels as indicated by its inhibition by carbenox-
olone, a connexin-43 gap junction inhibitor (De Vuyst et al., 2007)
and by connexin-43 silencing.
Previous work has implicated connexin-43 channels in ATP
release from various cells including astrocytes, neuronal precur-
sors, neutrophils and myocytes, in response to different stimuli
such as hypoxia, ischemia, and PAMPs (Clarke et al., 2009; Do-
browolski et al., 2008; Eltzschig et al., 2006; Faigle et al., 2008;
Goldberg et al., 2002; Kang et al., 2008; Lampe and Lau, 2004;
Liu et al., 2010; Solan and Lampe, 2007). Connexin-43 is main-
tained in a closed state through phosphorylation by several
kinases including PKC, MAPK, and AKT (Faigle et al., 2008;
Lampe and Lau, 2004) and is opened upon its dephosphorylation
(Faigle et al., 2008). We found that macrophage infection with
B. anthracis resulted in dephosphorylation of connexin-43,
which could be prevented by constitutive AKT activation.
Although AKT is not a direct target for LF-mediated proteolysis,
it is phosphorylated by the p38-responsive protein kinase MK2
at Ser473 (Seimon et al., 2009; Taniyama et al., 2004). In fact,
MK2 in a complex with p38, hsp27, and AKT is activated by
p38 to subsequently phosphorylate AKT at Ser473 (Seimon
et al., 2009; Taniyama et al., 2004). Thus, cleavage of MEK6 by
LF is directly responsible for loss of p38 MAPK activity in
B. anthracis-infected macrophages and this leads to diminished
expression of survival genes and loss of AKT activity. The latter is
likely to be responsible for connexin-43 opening and initial ATP
release by infected macrophages. The amount of ATP released
prior to the onset of massive macrophage death is sufficient
for inflammasome activation and IL-1b secretion. Interestingly,
IL-1b maintains macrophage survival and this may limit further
ATP release. However, if the initial release of IL-1b is not suffi-
cient for prevention of macrophage death, more ATP is likely to
be released at later stages when membrane integrity is lost,
leading to inflammasome activation in neighboring macro-
phages that are yet to die. Thus, inflammasome activation may
be controlled by a competition between B. anthracis-induced
macrophage death and IL-1b-induced macrophage survival.
Importantly, by directly responding to a ‘‘danger’’ signal, the in-
flammasome is only activated upon infection with a virulent
bacterium that cannot evade this critical component of innate
immunity whose activation depends on an abundant molecule
that is important to all life forms—ATP.SUPPLEMENTAL INFORMATION
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